Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif
Özet
New Schiff base-bearing thiosemicarbazones (1–13) were obtained from 4-hydroxy-3,5-dimethoxy benzaldehyde and various isocyanates. The structures of the synthesized molecules were elucidated in detail. Density functional theory calculations were also performed to determine the spectroscopic properties of the compounds. Moreover, the enzyme inhibition activities of these compounds were investigated. They showed highly potent inhibition effects on acetylcholinesterase (AChE) and human carbonic anhydrases (hCAs) (KI values are in the range of 51.11 ± 6.01 to 278.10 ± 40.55 nM, 60.32 ± 9.78 to 300.00 ± 77.41 nM, and 64.21 ± 9.99 to 307.70 ± 61.35 nM for AChE, hCA I, and hCA II, respectively). In addition, molecular docking studies were performed, confirmed by binding affinities studies of the most potent derivatives. © 2022 Deutsche Pharmazeutische Gesellschaft.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Demir, Yeliz | |
| dc.contributor.author | Türkeş, Cüneyt | |
| dc.contributor.author | Çavuş, Muhammet S. | |
| dc.contributor.author | Erdoğan, Musa | |
| dc.contributor.author | Muğlu, Halit | |
| dc.contributor.author | Yakan, Hasan | |
| dc.contributor.author | Beydemir, Şükrü | |
| dc.date.accessioned | 2026-10-18T20:27:20.665908131Z | |
| dc.date.available | 2026-10-18T20:27:20.665908131Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | New Schiff base-bearing thiosemicarbazones (1–13) were obtained from 4-hydroxy-3,5-dimethoxy benzaldehyde and various isocyanates. The structures of the synthesized molecules were elucidated in detail. Density functional theory calculations were also performed to determine the spectroscopic properties of the compounds. Moreover, the enzyme inhibition activities of these compounds were investigated. They showed highly potent inhibition effects on acetylcholinesterase (AChE) and human carbonic anhydrases (hCAs) (KI values are in the range of 51.11 ± 6.01 to 278.10 ± 40.55 nM, 60.32 ± 9.78 to 300.00 ± 77.41 nM, and 64.21 ± 9.99 to 307.70 ± 61.35 nM for AChE, hCA I, and hCA II, respectively). In addition, molecular docking studies were performed, confirmed by binding affinities studies of the most potent derivatives. © 2022 Deutsche Pharmazeutische Gesellschaft. | |
| dc.description.sponsorship | Funding text 1: The author would like to thank the Research Fund of Anadolu University (grant number 2102S003). The DFT calculations reported in this paper were partially performed at TUBITAK ULAKBIM, High Performance and Grid Computing Center (TRUBA resources).; Funding text 2: The author would like to thank the Research Fund of Anadolu University (grant number 2102S003). The DFT calculations reported in this paper were partially performed at TUBITAK ULAKBIM, High Performance and Grid Computing Center (TRUBA resources). | |
| dc.identifier.doi | 10.1002/ardp.202200554 | |
| dc.identifier.issn | 0365-6233 | |
| dc.identifier.issue | 4 | |
| dc.identifier.pmid | 36575148 | |
| dc.identifier.scopus | 2-s2.0-85145266945 | |
| dc.identifier.startpage | 2200554 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/12443 | |
| dc.identifier.volume | 356 | |
| dc.language.iso | en | |
| dc.publisher | John Wiley and Sons Inc | |
| dc.relation.ispartof | Archiv der Pharmazie | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | DFT | |
| dc.subject | enzyme inhibition | |
| dc.subject | molecular docking | |
| dc.subject | spectroscopic elucidation | |
| dc.subject | thiosemicarbazones | |
| dc.subject | Acetylcholinesterase | |
| dc.subject | Benzaldehydes | |
| dc.subject | Carbonic Anhydrase I | |
| dc.subject | Carbonic Anhydrase II | |
| dc.subject | Carbonic Anhydrase Inhibitors | |
| dc.subject | Cholinesterase Inhibitors | |
| dc.subject | Density Functional Theory | |
| dc.subject | Humans | |
| dc.subject | Molecular Docking Simulation | |
| dc.subject | Molecular Structure | |
| dc.subject | Structure-Activity Relationship | |
| dc.subject | 4 hydroxy 3,5 dimethoxy benzaldehyde | |
| dc.subject | benzaldehyde derivative | |
| dc.subject | carbonate dehydratase inhibitor | |
| dc.subject | cholinesterase inhibitor | |
| dc.subject | glyoxylic acid | |
| dc.subject | isocyanic acid derivative | |
| dc.subject | n (2 chlorophenyl) 2 (4 hydroxy 3,5 dimethoxybenzylidene)hydrazine 1 carbothioamide | |
| dc.subject | n (2 methoxyphenyl) 2 (4 hydroxy 3,5 dimethoxybenzylidene)hydrazine 1 carbothioamide | |
| dc.subject | n (3 chlorophenyl) 2 (4 hydroxy 3,5 dimethoxybenzylidene)hydrazine 1 carbothioamide | |
| dc.subject | n (3 methoxyphenyl) 2 (4 hydroxy 3,5 dimethoxybenzylidene)hydrazine 1 carbothioamide | |
| dc.subject | n (4 fluorophenyl) 2 (4 hydroxy 3,5 dimethoxybenzylidene)hydrazine 1 carbothioamide | |
| dc.subject | n (4 methylphenyl) 2 (4 hydroxy 3,5 dimethoxybenzylidene)hydrazine 1 carbothioamide | |
| dc.subject | n (4 nitrophenyl) 2 (4 hydroxy 3,5 dimethoxybenzylidene)hydrazine 1 carbothioamide | |
| dc.subject | n allyl 2 (4 hydroxy 3,5 dimethoxybenzylidene)hydrazine 1 carbothioamide | |
| dc.title | Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 81 | |
| rdl.department | Department of Biochemistry, Faculty of Pharmacy, Erzincan Binali Yıldırım University, Erzincan, Turkey. | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | PUBMED |
